Evidence map›Paper›PMID 39669406›Full record

ArticleThe Lancet regional health. Europe2024

Platelet transfusion in neonatal intensive care units of 22 European countries: a prospective observational study.

Nina A M Houben, Enrico Lopriore, Karin Fijnvandraat, Camila Caram-Deelder, Marta Aguar Carrascosa, Alain Beuchée, Kristin Brække, Francesco Cardona, Anne Debeer, Sara Domingues and 23 more

Abstract read
In one paragraph

Article in The Lancet regional health. Europe, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Observational
  7. Plasma transfusions in neonatal intensive care units: a prospective observational study.Archives of disease in childhood. Fetal and neonatal edition · 2025
    Observational
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Nina A M HoubenSanquin Research, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
Enrico LoprioreLeiden University Medical Centre, Leiden, the Netherlands.
Karin FijnvandraatAmsterdam UMC, University of Amsterdam, Emma Children's Hospital, Pediatric Hematology, Meibergdreef 9, Amsterdam, the Netherlands.
Camila Caram-DeelderLeiden University Medical Centre, Leiden, the Netherlands.
Marta Aguar CarrascosaLa Fe University Hospital, Valencia, Spain.
Alain BeuchéeCHU de Rennes, Rennes, France.
Kristin BrækkeOslo University Hospital, Oslo, Norway.
Francesco CardonaMedical University Vienna, Vienna, Austria.
Anne DebeerUZ Leuven, Leuven, Belgium.
Sara DominguesCentro Materno-Infantil do Norte - Unidade Local de Saúde de Santo António, Porto, Portugal.
Stefano GhirardelloFondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Ruza GrizeljUniversity Hospital Centre Zagreb, University of Zagreb, School of Medicine, Zagreb, Croatia.
Emina HadžimuratovićUniversity Medical Centre Sarajevo, Sarajevo, Bosnia and Herzegovina.
Christian HeiringDepartment of Neonatal and Paediatric Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Jana Lozar KrivecUniversity of Ljubljana, Faculty of Medicine, Ljubljana, Slovenia.
Jan MalýUniversity Hospital Hradec Králové, Hradec Králové, Czech Republic.
Katarina MatasovaJessenius Faculty of Medicine, University Hospital Martin, Martin, Slovakia.
Carmel Maria MooreUniversity College Dublin, Dublin, Ireland.
Tobias MuehlbacherUniversity Hospital Zurich, Zurich, Switzerland.
Miklos SzabóDepartment of Neonatology Semmelweis University, Budapest, Hungary.
Tomasz SzczapaII Department of Neonatology, Poznan University of Medical Sciences, Poznan, Poland.
Gabriela ZaharieUniversity of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.
Justine de JagerLeiden University Medical Centre, Leiden, the Netherlands.
Nora Johanna Reibel-GeorgiCharité - Universitätsmedizin Berlin, Berlin, Germany.
Helen V NewNHS Blood and Transplant, London, United Kingdom.
Simon J StanworthNHS Blood and Transplant, London, United Kingdom.
Emöke DeschmannKarolinska Institute, Stockholm, Sweden.
Charles C RoehrNational Perinatal Epidemiology Unit, Oxford Population Health, University of Oxford, Oxford, United Kingdom.
Christof DameCharité - Universitätsmedizin Berlin, Berlin, Germany.
Saskia le CessieLeiden University Medical Centre, Leiden, the Netherlands.
Johanna van der BomLeiden University Medical Centre, Leiden, the Netherlands.
Suzanne Fustolo-GunninkSanquin Research, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
INSPIRE Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Platelet transfusions are given to preterm infants with severe thrombocytopenia aiming to prevent haemorrhage. The PlaNeT2/MATISSE trial revealed higher rates of mortality and/or major bleeding in preterm infants receiving prophylactic platelet transfusions at a platelet count threshold of 50 × 10 Methods: We performed a prospective observational study in 64 neonatal intensive care units across 22 European countries between September 2022 and August 2023. Outcome measures included observed transfusion prevalence rates (per country and overall, pooled using a random effects Poisson model), expected rates based on patient-mix (per country, estimated using logistic regression), cumulative incidence of receiving a transfusion by day 28 (with death and discharge considered as competing events), transfusion indications, volumes and infusion rates, platelet count triggers and increment, and adverse effects. Findings: We included 1143 preterm infants, of whom 71 (6.2%, [71/1143]) collectively received 217 transfusions. Overall observed prevalence rate was 0.3 platelet transfusion days per 100 admission days. By day 28, 8.3% (95% CI: 5.5-11.1) of infants received a transfusion. Most transfusions were indicated for threshold (74.2%, [161/217]). Pre-transfusion platelet counts were above 25 × 10 Interpretation: The restrictive threshold of 25 × 10 Funding: Sanquin, EBA, and ESPR.

Indexed as

EpidemiologyEuropeNeonatal intensive care unitNeonatologyPlatelet transfusionPreterm infantsThrombocytopenia

Identifiers

PMID39669406
PMCPMC11635195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.